| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 22614 | 2017 |
| Third universal definition of myocardial infarction K Thygesen, JS Alpert, AS Jaffe, ML Simoons, BR Chaitman, HD White circulation 126 (16), 2020-2035, 2012 | 17447* | 2012 |
| Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ... New England Journal of Medicine 354 (16), 1706-1717, 2006 | 3748 | 2006 |
| Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial SR Steinhubl, PB Berger, JT Mann III, ETA Fry, A DeLago, C Wilmer, ... Jama 288 (19), 2411-2420, 2002 | 3635 | 2002 |
| Variability in platelet responsiveness to clopidogrel among 544 individuals VL Serebruany, SR Steinhubl, PB Berger, AI Malinin, DL Bhatt, EJ Topol Journal of the American College of Cardiology 45 (2), 246-251, 2005 | 1068 | 2005 |
| Enoxaparin vs unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary … SYNERGY Trial Investigators Jama 292 (1), 45-54, 2004 | 1048 | 2004 |
| Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial DL Bhatt, MD Flather, W Hacke, PB Berger, HR Black, WE Boden, ... Journal of the American College of Cardiology 49 (19), 1982-1988, 2007 | 999 | 2007 |
| CREDO Investigators. Clopidogrel for the Reduction of Events During Observation: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention … SR Steinhubl Jama 288, 2411-2420, 2002 | 863 | 2002 |
| The emerging field of mobile health SR Steinhubl, ED Muse, EJ Topol Science translational medicine 7 (283), 283rv3-283rv3, 2015 | 707 | 2015 |
| Aspirin dose for the prevention of cardiovascular disease: a systematic review CL Campbell, S Smyth, G Montalescot, SR Steinhubl Jama 297 (18), 2018-2024, 2007 | 629 | 2007 |
| Platelet function monitoring in patients with coronary artery disease PA Gurbel, RC Becker, KG Mann, SR Steinhubl, AD Michelson Journal of the American College of Cardiology 50 (19), 1822-1834, 2007 | 617 | 2007 |
| Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration B Freedman, J Camm, H Calkins, JS Healey, M Rosenqvist, J Wang, ... Circulation 135 (19), 1851-1867, 2017 | 553 | 2017 |
| Can mobile health technologies transform health care? SR Steinhubl, ED Muse, EJ Topol Jama 310 (22), 2395-2396, 2013 | 548 | 2013 |
| 2017 cardiovascular and stroke endpoint definitions for clinical trials KA Hicks, KW Mahaffey, R Mehran, SE Nissen, SD Wiviott, B Dunn, ... Circulation 137 (9), 961-972, 2018 | 511 | 2018 |
| Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial SE Nissen, SJ Nicholls, K Wolski, J Rodés-Cabau, CP Cannon, ... Jama 299 (13), 1547-1560, 2008 | 482 | 2008 |
| Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU … SR Steinhubl, JD Talley, GA Braden, JE Tcheng, PJ Casterella, ... Circulation 103 (21), 2572-2578, 2001 | 476 | 2001 |
| Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention G Montalescot, HD White, R Gallo, M Cohen, PG Steg, PEG Aylward, ... New England Journal of Medicine 355 (10), 1006-1017, 2006 | 454 | 2006 |
| Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials VL Serebruany, SR Steinhubl, PB Berger, AI Malinin, JS Baggish, ... The American journal of cardiology 95 (10), 1218-1222, 2005 | 448 | 2005 |
| Why have antioxidants failed in clinical trials? SR Steinhubl The American journal of cardiology 101 (10), S14-S19, 2008 | 436 | 2008 |
| Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High … PB Berger, DL Bhatt, V Fuster, PG Steg, KAA Fox, M Shao, DM Brennan, ... Circulation 121 (23), 2575-2583, 2010 | 434* | 2010 |
